Development of mitoxantrone (Q41906095)

13 October 2017

title

Development of mitoxantrone (English)

1 reference

13 October 2017

R J White

1

1 reference

13 October 2017

F E Durr

series ordinal

2

1 reference

13 October 2017

publication date

1 January 1985

1 reference

Investigational New Drugs

13 October 2017

published in

1 reference

13 October 2017

volume

3

1 reference

13 October 2017

issue

2

1 reference

13 October 2017

page(s)

85-93

1 reference

Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. I. Clinical observations

13 October 2017

cites work

1 reference

12 December 2020

Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy

1 reference

12 December 2020

Effects of 9,10-anthracenedione, 1,4-bis[(2-[(2-hydroxyethyl)amino]-ethyl)amino]-diacetate on cell survival and cell cycle progression in cultured mammalian cells

1 reference

12 December 2020

Inhibition of adriamycin-stimulated microsomal lipid peroxidation by mitoxantrone and ametantrone, two new anthracenedione antineoplastic agents

1 reference

12 December 2020

Activity of mitoxantrone in a human tumor cloning system

1 reference

12 December 2020

Anthracycline cardiomyopathy monitored by morphologic changes

1 reference

12 December 2020

Experimental antitumor activity of aminoanthraquinones

1 reference

12 December 2020

DNA-binding specificity and RNA polymerase inhibitory activity of bis(aminoalkyl)anthraquinones and bis(methylthio)vinylquinolinium iodides

1 reference

12 December 2020

Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology

1 reference

12 December 2020

Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics

1 reference

12 December 2020

Comparison of the interaction of antineoplastic aminoanthraquinone analogs with DNA using competitive fluorescence polarization

1 reference

12 December 2020

Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells

1 reference

12 December 2020

Direct and indirect clastogenic activity of anthracenedione in Chinese hamster ovary cells

1 reference

12 December 2020

Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids

1 reference

12 December 2020

Cellular uptake and inhibition of DNA synthesis by dihydroxyanthraquinone and two analogues

1 reference

12 December 2020

Effect of 1,4-dihydroxy-5,8-bis (2-(2-hydroxyethylamino) ethyl amino)-9,10-anthracenedione(dihydroxyanthraquinone) on the replication of simian virus 40 chromosome

1 reference

12 December 2020

Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro.

1 reference

12 December 2020

Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells

1 reference

12 December 2020

Differential effects of anthracycline drugs on rat heart and liver microsomal reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation

1 reference

12 December 2020

Sister-chromatid exchange and chromosomal aberrations by DHAQ and related anthraquinone derivatives in Chinese hamster ovary cells

1 reference

12 December 2020

Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones

1 reference

12 December 2020

Primary Bioassay of Human Tumor Stem Cells

1 reference

12 December 2020

Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00174154

1 reference

Dimensions Publication ID

13 October 2017

1046492696

0 references

1 reference